Recent News

Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma

January 22, 2021

This is a single-arm, open, II phase study to evaluate the safety and efficacy of Toripalimab, pemetrexed and carboplatin in the treatment of locally advanced malignant MPM in 15 newly diagnosed patients with locally advanced malignant MPM.

Thoracic Chemotherapy After Surgery Could Help Pleural Mesothelioma Patients Survive Longer

January 22, 2021

Hyperthermic intrathoracic chemotherapy alongside aggressive therapy (HITHOC) could help extend pleural mesothelioma patient survival. Doctors perform this by circulating a heated high concentration chemotherapy solution in the chest cavity for…

Mesothelioma Chemotherapy Resistance Could be Due to Cell Hibernation

January 15, 2021

Canadian researchers have discovered a cause of chemotherapy resistance in mesothelioma and other cancers. This is great news because this can lead to new treatments being created to combat the…

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors Enriched for Tumors With NF2 Gene Mutations

January 8, 2021

Primary Outcome Measures Occurrence of Dose Limiting Toxicity [ Time Frame: over the first 21 days of dosing ] Incidence of Adverse and Serious Adverse Events Occurrence of General Toxicity [ Time Frame: through study completion, an…

People with an Inherited Mutation on the BLM Gene Could Be More at Risk of Developing Mesothelioma

January 8, 2021

New research from the University of Hawaii is showing that the inherited mutation on the BLM gene can increase the chance of getting mesothelioma. The researchers sequenced the DNA of…

Cholesterol Drugs Called Statins Could Help Extend Mesothelioma Sufferers’ Lives

December 18, 2020

A group of drugs called statins used for controlling cholesterol are showing that they can help mesothelioma patients taking PD-1 inhibitors survive longer. Researchers in Italy and the Netherlands found…

The ONCOS-102 Vaccine is Still Showing Promising Results

December 11, 2020

The ONCOS-102 immunotherapy vaccine is still showing promising results. Information from November shows when patients take the treatment with chemotherapy, it helped patients survive a minimum of 18.2 months. The…

Peritoneal Mesothelioma Surgery with More organ Removal Can Help Survival

December 4, 2020

Mesothelioma surgery that removes more of an organ has been found to extend the survival of patients. It also did not increase the chance of severe complications nor did it…

Mesothelioma Symptom Management Tool Links Doctors and Patients with a Smartphone

November 20, 2020

A study looking at a system that connects doctors and patients with a smartphone is showing that it could make the management of mesothelioma symptoms easier. Mesothelioma is a fast…

The Herpes Virus is Being Tested as a Mesothelioma Treatment

November 13, 2020

An altered herpes virus is being tested in mesothelioma patients, and the results show that it can stabilize the growth of mesothelioma tumors. Half of the patients given the virus…